Companies House true 2024-11-01 2025-10-31 false 13674248 uk-bus:Director1 2024-11-01 2025-10-31 13674248 uk-bus:Director2 2024-11-01 2025-10-31 13674248 2024-11-01 2025-10-31 13674248 2025-10-31 13674248 uk-bus:EntityHasNeverTraded 2024-11-01 2025-10-31 13674248 uk-bus:FRS102 2024-11-01 2025-10-31 13674248 uk-bus:FullAccounts 2024-11-01 2025-10-31 13674248 uk-bus:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 13674248 2024-10-31 13674248 uk-bus:OrdinaryShareClass1 2024-11-01 2025-10-31 13674248 uk-bus:OrdinaryShareClass2 2024-11-01 2025-10-31 13674248 uk-bus:OrdinaryShareClass3 2024-11-01 2025-10-31 13674248 uk-bus:PreferenceShareClass1 2024-11-01 2025-10-31 13674248 uk-bus:PreferenceShareClass2 2024-11-01 2025-10-31 13674248 uk-bus:PreferenceShareClass3 2024-11-01 2025-10-31 13674248 uk-core:ShareCapitalPreferenceShares 2025-10-31 13674248 uk-core:ShareCapitalPreferenceShares 2024-10-31 iso4217:GBP iso4217:GBP xbrli:shares xbrli:shares

Registered Number 13674248

UK INARI BIOTECHNOLOGY GROUP CO., LTD.

Dormant Accounts

31 October 2025

## UK INARI BIOTECHNOLOGY GROUP CO., LTD. Registered Number 13674248

## Balance Sheet as at 31 October 2025

|  | 2025 | 2024
--- | --- | --- | ---
|  | £ | £
Called up share capital not paid |  | 100000 | 100000
Net assets |  | 100000 | 100000
Issued share capital
100000 Ordinary Shares of £ 1 each |  | 100000 | 100000
Total Shareholder funds |  | 100000 | 100000

### STATEMENTS

1. For the year ending 31 October 2025 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 31 October 2025

And signed on their behalf by:
Zhongtang SUN, Director